Financing Drug Discovery via Dynamic Leverage
with Vahid Montazerhodjat and John J. Frishkopf, Drug Discovery Today 21(2016), 410–414.
What Is An Index?
Journal of Portfolio Management 42(2016), 21–36.
Law Is Code: A Software Engineering Approach to Analyzing the United States Code
with William Li, Pablo Azar, David Larochelle, Phil Hill, Journal of Business & Technology Law 10(2015), 297–374.
Reply to “(Im)Possible Frontiers: A Comment”
with Thomas J. Brennan, Critical Finance Review 4(2015), 157–171.
Funding Translational Medicine via Public Markets: The Business Development Company
with Sandra M. Forman, Monica Shilling, Grace K. Sweeney, Journal of Investment Management 13(2015), 9–32.
Hedge Funds: A Dynamic Industry In Transition
with Mila Getmansky, Peter A. Lee, Annual Review of Financial Economics 7(2015), 483–577.
Return Smoothing, Liquidity Costs, and Investor Flows: Evidence from a Separate Account Platform
with Charles Cao, Grant Farnsworthy, Bing Liang, Management Science Vol. 63, No. 7, July 2017, pp. 2233–2250
A Survey of Systemic Risk Analytics
with Dimitrios Bisias, Mark Flood, and Stavros Valavanis, Annual Review of Financial Economics 4, 255-296
A Computational View of Market Efficiency
with Jasmina Hasanhodzic and Emanuele Viola, Quantitative Finance 7, 1043-1050
The Gordon Gekko Effect: The Role of Culture in the Financial Industry
Economic Policy Review 22(2016), 17–42.